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Background and aims: A number of Helicobacter pylori outer membrane proteins (OMPs) undergo phase
variations. This study examined the relation between OMP phase variations and clinical outcome.
Methods: Expression of H pylori BabA, BabB, SabA, and OipA proteins was determined by immunoblot.
Multiple regression analysis was performed to determine the relation among OMP expression, clinical
outcome, and mucosal histology.
Results: H pylori were cultured from 200 patients (80 with gastritis, 80 with duodenal ulcer (DU), and 40
with gastric cancer). The most reliable results were obtained using cultures from single colonies of low
passage number. Stability of expression with passage varied with OipA . BabA . BabB . SabA. OipA
positive status was significantly associated with the presence of DU and gastric cancer, high H pylori
density, and severe neutrophil infiltration. SabA positive status was associated with gastric cancer,
intestinal metaplasia, and corpus atrophy, and negatively associated with DU and neutrophil infiltration.
The Sydney system underestimated the prevalence of intestinal metaplasia/atrophy compared with
systems using proximal and distal corpus biopsies. SabA expression dramatically decreased following
exposure of H pylori to pH 5.0 for two hours.
Conclusions: SabA expression frequently switched on or off, suggesting that SabA expression can rapidly
respond to changing conditions in the stomach or in different regions of the stomach. SabA positive status
was inversely related to the ability of the stomach to secrete acid, suggesting that its expression may be
regulated by changes in acid secretion and/or in antigens expressed by the atrophic mucosa.
A
dherence of Helicobacter pylori to the gastric mucosa is
believed to play an important role in the inflammatory
response to the organism.1 At least 32 H pylori outer
membrane proteins (OMPs) have been identified, many of
which are involved in bacterial adherence.2 A number of the
genes encoding these OMPs undergo phase variations in the
59 region such that not all strains produce functional
proteins. Five genes encoding OMPs (oipA, sabA, sabB, babB,
and hopZ) are thought to be regulated by the slipped strand
mispairing based on the number of CT dinucleotide repeats in
the 59 region of the genes such that when inframe the gene is
‘‘on’’ and when out of frame it is ‘‘off’’.2 3
Fucosylated ABO blood group antigens and the related
sialyl-Lewis x and sialyl-Lewis a antigens (sLex and sLea)
have been identified as functional receptors for H pylori
adherence.4 5 ABO antigens are recognised by the blood group
antigen binding adhesin BabA6 whereas sLex/a is recognised
by the sialic acid binding adhesin SabA.5 The outer
inflammatory protein OipA also has been suggested to have
a role in binding but the cognate receptor structure remains
unknown.7
Recent studies have suggested H pylori expressing BabA
and OipA are associated with more severe mucosal cellular
inflammation and an increased risk of clinical outcomes such
as peptic ulcer disease and gastric cancer.8–14 However, not all
studies agree.14–16 Most of the available studies determined
OMP functional status indirectly by examining genomic
variations using mismatch polymerase chain reaction (PCR)
(for the babA2 gene)8–10 14 15 and PCR based sequencing for
detecting the number of CT repeats (for the oipA, sabA, and
hopZ genes).12 13 15 16 However, the high degree of genetic
diversity among H pylori complicates interpretation of PCR
based methods and may result in an underestimation of the
frequency of the functional status of the gene (that is, silent
genes may be scored as expressed and chimeric H pylori OMPs
as non-expressed).17–19 For example, it has been demonstrated
that many Leb non-binding strains possess silent babA gene
sequences which may become activated by recombination
into the babB locus forming chimeric babB/A genes.17
Recombination events between two babA genes may also
result in a change in ABO antigen receptor specificity.18 In the
present study, we used immunoblotting to directly evaluate
the protein expression status of OipA, BabA, BabB, and SabA
in relation to clinical outcomes and to gastric histology.
MATERIALS AND METHODS
Bacterial strains
We examined H pylori isolates cultured from patients from
South America (Colombia) and the USA. Presentations
included simple H pylori gastritis, duodenal ulcer (DU)
disease, and advanced non-cardiac gastric adenocarcinoma.
DU was defined endoscopically; patients with ulcer scars
were excluded as were those with DU and gastric ulcer.
Patients who used non-steroidal anti-inflammatory drugs
were also excluded. Gastritis was defined as histological
gastritis only. None of the strains had been published in our
prior studies of H pylori virulence factors. Additional selection
criteria included at least eight gastric mucosal biopsies for
Colombian patients and more than five for US patients. We
excluded gastric cancer cases from the USA due to the small
numbers available.
Abbreviations: BHI, brain heart infusion; bp, base pair; DU, duodenal
ulcer; FBS, fetal bovine serum; IM, intestinal metaplasia; Le, Lewis
antigen; OMP, outer membrane protein; OR, odds ratio; PCR,
polymerase chain reaction
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Gastric histology
Gastric mucosal biopsy specimens were stained with Genta20
or El-Zimaity triple stains.21 Sections were examined by the
pathologist who was blinded to the patient’s clinical
diagnosis or the characteristics of the H pylori strain. We
examined up to five biopsy specimens from the antrum (A1
from the antral lesser curvature within 2 cm of the pylorus,
A2 from the mid lesser curvature of the antrum, A3 from the
gastric angle, A4 from the antral greater curvature within
2 cm of the pylorus, and A5 from the mid greater curvature of
the antrum) and up to six specimens from the corpus (B1
from the greater curvature proximal to the antral-corpus
border, B2 from the greater curvature at least 4 cm proximal
to the antral-corpus border, B3 from the proximal greater
curvature, B4 from the proximal lesser curvature, B5 from the
lesser curvature within 5 cm of the anglus, and B6 from the
greater curvature in the mid corpus). Each specimen was
scored for H pylori density, neutrophil infiltration, intestinal
metaplasia (IM), and atrophy. All variables were scored using
a visual analogue scale graded from 0 (absent/normal) to 5
(maximal intensity), as described previously.22 Scores in each
site were averaged both in the antrum and corpus.
H pylori phenotyping
Antral specimens (from A4 or A5) were obtained for isolation
of H pylori using standard culture methods.23 24 In order to
minimise the risk of phase variations, H pylori samples were
obtained by expansion of a single colony. To reduce the
likelihood of a change in OMP phase status during in vitro
passage, we used H pylori with in vitro passage numbers less
than 4 (including the expansion from a single colony). We
compared the results using cultures grown from multiple
colonies with those grown from single colonies. We also
evaluated the effect of multiple in vitro passages (10 and 20
times) and compared the results using cultures obtained
from antral and corporal biopsy specimens (B6). Unless
stated otherwise, experiments were done with low passage
number H pylori grown from single colonies obtained from
antral biopsies.
We used actively replicating organisms obtained after 20–
24 hours of incubation which corresponds to the logarithmic
growth phase; immunoblotting was performed using stan-
dard methods. Anti-BabA antiserum (AK277),25 anti-BabB
antiserum (AK276),25 anti-OipA antiserum (AK282),26 and
anti-SabA antiserum (AK278)27 were used as the first
Table 1 Univariate analysis of relationship between Helicobacter pylori genotyping and clinical outcome
Gastritis DU Gastric cancer
p Value
DU v gastritis Cancer v DU
Cancer v
gastritis
All samples n = 80 n = 80 n = 40
BabA 70% 84% 88% 0.061 NS 0.059
BabB 70% 71% 55% NS NS NS
SabA 66% 44% 70% 0.007 0.012 NS
OipA 61% 88% 89% ,0.001 NS 0.006
CagA 69% 85% 90% 0.024 NS 0.019
Colombian samples n = 40 n = 40 n = 40
BabA 68% 83% 88% NS NS 0.059
BabB 68% 73% 55% NS NS NS
SabA 63% 40% 70% 0.073 0.008 NS
OipA 60% 90% 89% 0.004 NS 0.010
CagA 68% 85% 90% NS NS 0.027
US samples n = 40 n = 40
BabA 73% 85% – NS – –
BabB 73% 70% – NS – –
SabA 70% 48% – 0.069 – –
OipA 63% 85% – 0.041 – –
CagA 70% 85% – NS – –
p value was determined by Fisher’s exact test. NS, not significant (p.0.1).
DU, duodenal ulcer.
Table 2 Multiple logistic regression analysis: Helicobacter pylori factors associated with
clinical presentation
Factor p Value
Adjusted
OR 95% CI
Duodenal ulcer v gastritis
All samples OipA 0.004 4.0 1.6–10.2
SabA 0.061 0.52 0.27–1.0
Colombian samples OipA 0.005 9.0 1.9–42.2
SabA 0.047 0.34 0.12–0.98
US samples OipA 0.049 3.9 1.0–15.3
SabA 0.069 0.40 0.15–1.1
Gastric cancer v DU
All samples SabA 0.018 2.8 1.2–6.7
Colombian samples SabA 0.015 3.6 1.3–10.1
Gastric cancer v gastritis
All samples OipA 0.013 4.8 1.4–16.8
Colombian samples OipA 0.018 5.5 1.3–22.5
Factors with a p value less than 0.10 are presented. When we analysed data combining two counties (total),
country was also included in explanatory variables.
DU, duodenal ulcer; OR, odds ratio; 95% CI, 95% confidence interval.
776 Yamaoka, Ojo, Fujimoto, et al
www.gutjnl.com
 group.bmj.com on April 25, 2013 - Published by gut.bmj.comDownloaded from 
antibody at a 1:5000 dilution. Horseradish peroxidase
conjugated protein A (1:3000) (Bio-Rad Lab, Hercules,
California, USA) was used as the second antibody. Proteins
were detected by ECL chemiluminescent substrate detection
reagents (Amersham Life Science, Arlington Heights, Illinois,
USA). The accuracy of the immunoblot for antiserum against
BabA, BabB, OipA, and SabA was confirmed previously.25–27
As previous studies reported that oipA status was closely
related to cagA status12, we also examined CagA status using
commercial anti-CagA antibody (Austral Biologicals, San
Ramon, California, USA).
Acid exposure
After overnight culture, H pylori were suspended in brain
heart infusion (BHI) broth (pH 5.0) supplemented with 10%
fetal bovine serum (FBS). The pH of the media was adjusted
using concentrated hydrochloric acid prior to addition of H
pylori. After two hours of acid exposure, H pylori were
harvested and used for immunoblotting. Controls consisted
of cultures grown in pH 7.0 BHI broth for two hours.
Data analysis
For independent univariate analysis, Fisher’s exact test, the
Mann-Whitney rank sum test and t test were used,
depending on the data set of concern. A multiple logistic
regression analysis was performed to determine which
putative virulence factor(s) was the most discriminating for
clinical outcome. Bacterial factors, as well as age and sex,
were used as explanatory variables. Multiple linear regression
analyses were used for histological data as the data had a
normal distribution. In the analyses, bacterial factors, sex,
age, and clinical outcomes were the explanatory variables
and mutually adjusted associations with the criterion
variables were calculated. A p value of less than 0.05 was
accepted as statistically significant. Calculations were carried
out using statistical software ‘‘HALBAU’’ (Gendai-sugaku-
sha, Kyoto, Japan).
RESULTS
Strains from 200 patients were examined, including 120 from
Colombia (40 with gastritis, 40 with DU, and 40 with gastric
cancer) and 80 from the USA (40 with gastritis and 40 with
DU). Colombian patients comprised 71 men and 49 women
(mean age 52.5 years). US patients comprised 68 men and 12
women (mean age 54.2 years). Mean age of gastric cancer
patients (57.7 years) was significantly higher than that of DU
(51.3 years) or gastritis patients (48.5 years) (p,0.01 for
each). There were no significant differences in sex or age
distribution among the different clinical outcomes.
H pylori OMPs status and clinical outcomes
Independent univariate analysis using Fisher’s exact test
showed that OipA status was significantly associated with
DU (table 1). OipA was present more often in strains from
DU patients (88%) than in those from gastritis patients (61%)
(p,0.001), confirming previous studies evaluating OipA
status by genotyping.11 SabA positive status was less
prevalent in strains from DU patients (44%) compared with
those from gastritis patients (66%) (p,0.01) or from gastric
cancer patients (70%) (p,0.05).
Multiple logistic regression analysis among OMPs showed
that only the presence of OipA and SabA were related to
clinical outcome (table 2). Only OipA status was an
independent determinant predictor of gastric cancer versus
gastritis (adjusted odds ratio (OR) 4.8 (95% confidence
interval (CI) 1.4–16.8)) and DU versus gastritis (OR 4.0 (95%
CI 1.6–10.2)). Only SabA status was a predictor of gastric
cancer versus DU (OR 2.8 (95% CI 1.2–6.7)). The presence of
SabA was associated with a reduced risk of DU compared
with gastritis although the differences did not reach
statistical significance (OR 0.52 (95% CI 0.27–1.0)).
When we added CagA status as an explanatory variable for
the analyses, calculations could not be converged as OipA
and CagA status were generally identical. In fact, 188 of 200
(94%) samples showed identical CagA/OipA phenotype
(correlation coefficient 0.83) (p,0.001) (table 3). OipA,
CagA, and BabA protein status were significantly correlated
with one another in agreement with previous studies at the
genomic level.6 8 12 15 When we added CagA status and
eliminated OipA status, CagA status was a determinant
predictor of gastric cancer versus gastritis (OR 6.5 (95% CI
1.4–29.3)); however, it was not a predictor of DU versus
gastritis (OR 2.4 (95% CI 0.9–6.2)).
H pylori OMPs status and gastric mucosal histology
Histological analyses were performed in gastritis and DU
cases. Independent univariate analysis using the Mann-
Whitney rank sum test indicated that BabA, SabA, OipA, and
CagA status were closely related to changes in gastric
histology (table 4). As BabA, OipA, and CagA status were
not independent of one another (as described above), we
chose to look at all predictor variables at the same time and
performed a backward stepwise multiple linear regression
analysis. For this analysis, we used H pylori factors, including
CagA status as well as country and clinical outcome, as
explanatory variables. OipA positive status was significantly
associated with high H pylori density and grade of neutrophil
infiltration (table 5). In the analyses, the partial regression
coefficient 0.71 of OipA for H pylori density was interpreted as
showing that the H pylori density score with OipA positive
strains would be expected to be 0.71 points greater than with
OipA negative strains. SabA positive status was closely
associated with decreased neutrophil infiltration (antrum
and corpus) and with severe IM and gastric atrophy
(antrum) (table 5). SabA positive status also remained in
the final model for corporal IM and gastric atrophy although
the differences did not reach statistical significance. BabA
positive status was also significantly associated with severe
IM and gastric atrophy in the antrum (table 5). BabB positive
status remained in the final model for decreased neutrophil
infiltration; however, the differences did not reach statistical
significance. As scores for corporal IM were relatively low in
most cases, we also categorised IM as positive or negative (IM
at no sites). In agreement with multiple linear regression
analysis, only SabA status was independently related to
corporal IM (adjusted OR 4.6 (95% CI 1.5–14.2)).
In the present study, we examined 11 biopsy specimens
(five from the antrum and six from the corpus). Many
investigators have used the updated Sydney system which
recommends five biopsy specimens for histological analyses
(two from the antrum, two from the mid to proximal corpus,
and one from the gastric angle). We therefore re-evaluated
our samples according to that system (using biopsy sites A1,
A3, A4, B4, and B6). Results using five biopsy specimens and
11 biopsy specimens differed with respect to corporal IM and
Table 3 Relationship among the Helicobacter pylori
genotypes
BabA BabB SabA OipA CagA
BabA 0.58 0.38 ,0.001 ,0.001
BabB 0.04 0.88 0.86 0.35
SabA 0.07 0.02 0.17 0.21
OipA 0.51 0.02 0.10 ,0.001
CagA 0.54 0.08 0.10 0.83
Numbers above the diagonal space are p values using Fisher’s exact test,
and those below the diagonal space are Cramer’s correlation coefficient.
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atrophy (table 5). Using only two corporal biopsy specimens,
no factors remained in the final model for corporal IM and
different factors (CagA) remained in the final model for
corporal atrophy.
Recently, the Houston system for scoring corporal atrophy
was devised based on the fact that corpus atrophy advances
from the antrum into the corpus, extending up the lesser
curve followed by the greater curve.28 29 The system consisted
of a four point scale ranging from 0 = none to 3 = severe,
with 0 = atrophy at no corpus site, 1 = mild or atrophy only at
B4, 2 = moderate or atrophy at B2 and B4, and 3 = severe
atrophy, including B6. Using this system, SabA status
remained in the final model for atrophy and was statistically
significant (partial regression coefficient 0.63 (SEM 0.25);
p = 0.015), confirming the observation that the Sydney system
underestimates the frequency and severity of atrophy/IM.
Table 4 Univariate analysis of relationship between Helicobacter pylori genotyping and histology
Antrum Corpus
n
H pylori
density
Neutrophil
infiltration
Intestinal
metaplasia Atrophy
H pylori
density
Neutrophil
infiltration
Intestinal
metaplasia Atrophy
BabA
Positive 158 2.5 (2.6) 2.6 (2.5) 0.7 (0) 1.7 (1.2) 2.5 (2.7) 1.9 (2.1) 0.3 (0) 0.6 (0)
Negative 42 2.1 (2.1) 1.8 (1.8) 0.4 (0) 0.9 (0.6) 2.0 (1.9) 1.3 (1.0) 0.2 (0) 0.3 (0)
p value 0.018 0.002 NS 0.001 0.005 0.020 NS NS
BabB
Positive 135 2.4 (2.5) 2.4 (2.4) 0.7 (0) 1.4 (1.0) 2.4 (2.3) 1.8 (2.0) 0.3 (0) 0.5 (0)
Negative 65 2.4 (2.4) 2.5 (2.4) 0.7 (0) 1.6 (1.2) 2.5 (2.4) 1.7 (2.0) 0.3 (0) 0.6 (0)
p value NS NS NS NS NS NS NS NS
SabA
Positive 116 2.4 (2.6) 2.1 (2.4) 0.8 (0) 1.8 (1.3) 2.3 (2.0) 1.5 (1.7) 0.4 (0) 0.7 (0)
Negative 84 2.5 (2.5) 2.9 (2.7) 0.5 (0) 1.0 (0.6) 2.6 (2.8) 2.2 (2.0) 0.2 (0) 0.4 (0)
p value NS ,0.001 0.056 ,0.001 0.017 ,0.001 0.049 0.047
OipA
Positive 154 2.6 (2.7) 2.7 (2.5) 0.8 (0) 1.6 (1.0) 2.6 (2.8) 1.9 (2.0) 0.3 (0) 0.6 (0)
Negative 46 1.9 (1.8) 1.7 (1.8) 0.4 (0) 1.0 (0.9) 1.9 (2.1) 1.3 (1.0) 0.1 (0) 0.4 (0)
p value ,0.001 ,0.001 NS 0.021 ,0.001 0.005 NS NS
CagA
Positive 160 2.5 (2.6) 2.6 (2.5) 0.8 (0) 1.6 (1.0) 2.5 (2.7) 1.9 (2.0) 0.3 (0) 0.6 (0)
Negative 40 2.1 (1.9) 1.8 (1.9) 0.2 (0) 0.9 (0.6) 2.0 (2.1) 1.4 (1.1) 0.1 (0) 0.3 (0)
p value 0.029 0.003 0.030 0.005 0.010 0.054 0.031 0.098
NS, not significant, p.0.10.
For histological scores (minimum 0 to maximum 5), mean (median) are presented.
Table 5 Final model using multiple linear regression analysis: Helicobacter pylori factors associated with histology
Pathology Site Factor
Partial regression
coefficient* p Value
Multiple
correlation
coefficient
All 11 biopsy specimens
H pylori density Antrum OipA 0.71 (0.21) ,0.001 0.26
Corpus OipA 0.69 (0.18) ,0.001 0.37
SabA 20.29 (0.16) 0.071
Neutrophil infiltration Antrum OipA 1.13 (0.23) ,0.001 0.50
SabA 20.67 (0.21) 0.004
BabB 20.44 (0.28) 0.081
Corpus SabA 20.81 (0.19) ,0.001 0.38
OipA 0.46 (0.22) 0.037
BabB 20.43 (0.25) 0.082
Intestinal metaplasia Antrum BabA 0.48 (0.17) 0.004 0.36
SabA 0.32 (0.14) 0.026
Corpus SabA 0.10 (0.01) 0.080 0.29
Atrophy Antrum SabA 0.84 (0.19) ,0.001 0.55
BabA 0.89 (0.26) ,0.001
Corpus SabA 0.25 (0.12) 0.059 0.31
5 biopsy specimens (updated Sydney system)
H pylori density Antrum OipA 0.47 (0.22) 0.032 0.33
Corpus OipA 0.66 (0.19) ,0.001 0.29
Neutrophil infiltration Antrum OipA 0.85 (0.26) 0.001 0.46
SabA 20.64 (0.22) 0.004
BabB 20.55 (0.30) 0.071
Corpus SabA 20.60 (0.25) 0.010 0.40
OipA 0.60 (0.26) 0.019
Intestinal metaplasia Antrum SabA 0.44 (0.20) 0.035 0.51
BabA 0.51 (0.26) 0.049
OipA 0.49 (0.27) 0.070
Corpus None – – 0.12
Atrophy Antrum BabA 0.98 (0.27) ,0.001 0.51
SabA 0.79 (0.20) ,0.001
Corpus CagA 0.41 (0.24) 0.054 0.34
*Values are mean (SEM).
Factors with p value less than 0.10 are presented.
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Immunoblotting for H pylori factors from single
colonies and multiple colonies
The above analyses evaluated H pylori factors obtained from
single colonies. To confirm the accuracy of the immunoblot-
ting using single colonies, we examined 20 samples with
variable production patterns of OMPs (table 6). We re-
cultured frozen biopsy specimens from these 20 samples and
multiple colonies were harvested en masse. The results for
OipA and CagA were identical between multiple colonies and
a single colony. In contrast, half of the strains’ negative
results for SabA from a single colony (4/8 samples) yielded
positive results from multiple colonies (table 6). These
differences in phenotypic designation (negative becoming
positive results) were also observed with BabA (13%) and
BabB (25%). To confirm our results, we chose 20 colonies
from each strain where negative immunoblot results for SabA
using single colonies produced positive results using multiple
colonies (four samples). Immunoblot showed that mixed
SabA positive and negative strains were common, where 10–
15% of samples from a new single colony yielded positive
results despite SabA status having been characterised as
negative using with the original single colony (data not
shown). Thus one should probably describe the isolates as
being of the predominant phenotype. In a preliminary
experiment we found that if the samples contained more
than approximately 5% OMP positive strains, immunoblot
yielded positive results and this held true for all four OMPs
evaluated (data not shown). We also showed that the results
of single colony experiments usually identify the predomi-
nant phenotype (data not shown).
Effects of in vitro passages on H pylori phenotype
Previous studies reported that OMPs status may switch over
time in vivo and during in vitro laboratory passages.17–19 30 To
evaluate the effect of in vitro passages, we selected 20 strains
from those used in the above experiments (table 6). We used
the original strains grown from a single colony (passage
number less than 4) and transferred them 10 and 20 times in
vitro. OipA and CagA status did not change during 20
passages. In contrast, during 20 passages, BabA and BabB
status changed in 10% and SabA status changed in 25%
(table 6). Both changes (negative becoming positive results
and positive becoming negative results) were observed in
SabA and BabB whereas only the change from negative to
positive was observed in BabA. Changes were rare during 10
passages with the only change being one SabA which
changed to negative, suggesting that a passage number of
10 or less may best represent in vivo conditions.
Immunoblotting using H pylori from antral and corpus
biopsies
We compared results of immunoblotting of strains from the
antrum and corpus of the same patient. We selected 20
strains used in the above experiments (table 6) and cultured
H pylori from their corresponding corpus biopsy specimens. H
pylori proteins were extracted from bacteria grown from
single colonies. The results for antral and corpus specimens
were identical (data not shown).
Effect of low acid condition on H pylori phenotype
The above in vivo results showing that SabA was associated
with gastric cancer and the severity of gastric atrophy/IM
suggested that SabA expression may be regulated by changes
in the intragastric milieu, such in pH. To test this hypothesis,
we compared cultures grown in high acid conditions (pH 5.0)
with those grown at pH 7.0. We selected 10 strains (Nos 1–10
in table 6). Our preliminary experiments showed that
virtually all H pylori survived the two hours of acid exposure
in BHI broth at pH 5.0 (data not shown). Two hours of acid
exposure did not result in any change in status for CagA or
the OMPs, with the exception of expression of SabA which
was dramatically decreased in three of the five stains (fig 1).
We therefore further examined these three strains following
Table 6 Changing of outer membrane protein (OMP) status by multiple colonies and multiple in vitro passages
No Strain Disease
Initial OMP status (single colonies with
low passages) OMPs with changed status
BabA BabB SabA OipA CagA
Multiple colonies
(changed from 2 to +)
Multiple in vitro passages
(initial/10 times/20 times)
1 C693 Gastritis + 2 2 + + SabA, BabB SabA (2/2/+), BabB (2/2/+)
2 C185 Gastritis 2 2 2 2 2 SabA, BabB
3 C382 Gastritis + + 2 2 2 SabA SabA (2/2/+)
4 C434 DU + 2 2 + + SabA
5 C144 GC 2 + + + + BabA
6 C145 GC + + + + + SabA (+/+/2), BabA (+/+/2)
7 C436 DU + + + 2 2 SabA (+/2/2), BabB (+/+/2)
8 C239 Gastritis + + 2 2 2 SabA (2/2/+)
9 C149 GC + 2 + + + BabA (+/+/2)
10 C200 Gastritis + + + + +
11 C433 DU + + + + +
12 C427 DU + + + + +
13 C135 GC + + + + +
14 C138 GC + + 2 + +
15 C447 DU 2 + + 2 2
16 C90 Gastritis 2 + + 2 2
17 C288 DU 2 2 + 2 2
18 C272 Gastritis 2 2 2 + +
19 C109 DU 2 2 2 + +
20 C401 GC 2 2 + 2 2
DU, duodenal ulcer, GC, gastric cancer.
Figure 1 Effect of low pH on SabA expression by immunoblot analysis.
Helicobacter pylori was exposed to pH 7.0 and pH 5.0 broth for two
hours. Equal amounts of protein were separated on a 10%
polyacrylamide gel, transferred to nitrocellulose membranes, and
probed with an anti-SabA antiserum (AK278). SabA expression was
decreased in acidic conditions in strains C144, C145, and C436.
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exposure to pH 5.5 in BHI broth supplemented with 10% FBS
for 20–24 hours, with shaking at 200 rpm. We used pH 5.5 as
apparent logarithmic growth phase of H pylori was not
observed during 24 hours of culture in broth at pH 5.0. SabA
status changed from positive to negative in one strain (C436)
and expression of SabA decreased in the other two strains
(data not shown).
DISCUSSION
There has been increasing interest in the role of H pylori
OMPs, especially OipA and BabA, in gastroduodenal dis-
ease.8–14 Our studies confirmed previous observations with
OipA and BabA and report new findings in relation to SabA
and clinical outcome and gastric histology. OipA and CagA
appear to be stably expressed. In contrast, BabA and SabA
were prone to undergo phase variations. The stomach
presents a variety of different microenvironments such that
the ability to switch ‘‘on’’ and ‘‘off’’ various adhesins and
surface proteins may offer survival advantages to the
bacteria. For example, deep in the pits in the antrum the
bacteria would be exposed to different populations of cells
compared with those on the luminal surface, as well as a
much lower fluctuations in pH. The fact that SabA expression
was increased in strains obtained from patients with gastric
cancer and prevalence was reduced among those with DU
suggested that switching may be related to intragastric pH.
We showed that SabA expression was dramatically decreased
at pH 5. This result is in agreement with a previous study
using microarray that expression levels of sabA mRNA
decreased in acidic conditions.31 It would be interesting to
examine SabA status among patients undergoing long term
acid suppression as well as its possible role in proton pump
inhibitor associated increased corpus inflammation.32
SabA expression was also increased in patients with
intestinal metaplasia and gastric atrophy, suggesting that
there may be a relation between SabA and the antigens/
receptors expressed by this altered epithelium. In contrast,
BabA expression was associated with both high and low acid
conditions (for example, gastric cancer and DU),8–14 suggest-
ing that phase variations of BabA are unlikely to be
influenced by intragastric pH and/or the change in gastric
mucosal cell types.
SabA has been suggested to be a sialic acid binding
adhesin.5 Other studies have suggested that SabA is
responsible for binding of H pylori bacterial cells to ganglio-
sides.33 During persistent infection and chronic inflammation
(gastritis), H pylori triggers an alteration in the patterns of
glycosylation in the gastric mucosa, including upregulation of
the inflammation associated sLex antigens. It has been
suggested that SabA performs selectin mimicry by binding
the sialyl-(di)-Lex/a glycosphingolipids promoting membrane
attachment and apposition. It is possible (or suggested) that
at sites of vigorous local inflammatory response, H pylori
undergo phase variations and switch off the sLex binding
capacity, allowing non-functional SabA to escape intimate
contact with sialylated lymphocytes or other defensive cells.
Thus SabA should be involved in adaptation of bacterial
adherence properties to inflammation pressure.
We also directly examined the relationship between
expression of SabA protein and clinical outcome. Previous
studies indirectly evaluated SabA status using PCR to assess
whether the gene was likely ‘‘on’’ or ‘‘off’’. Lehours and
colleagues15 reported that combination of the sabA ‘‘on’’
status with hopZ ‘‘off’’ status and iceA1 allele was related to
an increased risk of mucosa associated lymphoid tissue
lymphoma. In contract, de Jonge and colleagues16 evaluated
SabA status by the number of CT repeats in a small study (for
example, nine gastric cancers) and reported that sabA ‘‘on’’
status had no relation to clinical outcome. In that study, they
considered all strains with 7¡3 CT repeats as gene ‘‘on’’ status.
However, recent reports have shown that the sabA gene can be
‘‘on’’ or ‘‘off’’ depending on the nucleotide sequence after the CT
repeats. The presence of sabA ‘‘off’’ status strains has been
confirmed among strains with seven CT repeats,15 suggesting
that conclusions based on PCR based methods for SabA status
should be interpreted with caution. This caution also applies to
BabA in that distinguishing babA2 from babA1 based on 10 bp
deletion of the signal peptide sequence may provide miscate-
gorisations as regulation by the 10 bp deletion appears to be
specific for strain CCUG178756 as no other strain containing
two babA genes called 1 and 2 has been reported. Recent data
showed that BabA expression was also regulated at the level of
transcription and by formation of the chimeric babA-babB
gene.17–19 In the present study, BabA status was changeable
during in vitro passages. Further studies are necessary to
determine the mechanism (for example, differences in the
poly(A) tract in the babA promoter, existence of recombination
events between babA and babB).
Overall, because of the technical difficulties in evaluating
OMPs status by PCR, we suggest that currently the most
reliable method is to confirm protein expression by immuno-
blot. That said, there are important methodological cautions,
including the use of single colonies, low in vitro passage
number, and confirmation by evaluating H pylori obtained
from different regions of the stomach. These cautions are
based on the finding of a relatively high frequency of
coexistence of H pylori expressing and not expressing the
factor of interest. The frequency of mixed expression was
highest with SabA, less with BabB and BabA, and very rare
with OipA. Our data suggest that the single colony method
usually represents the predominant phenotype whereas the
multiple colonies method is biased towards the presence of
positive strains in the sample. While study of the role of
different proportions of H pylori expressing putative virulence
factors in relation to outcome are theoretically interesting,
current technical limitations restrict analyses to studies based
on the predominant phenotype which cannot be reliably
determined using results from multiple colonies. We also
found that the problem of phase shifting during in vitro
passage could be minimised using low in vitro passage
number. Finally, we showed that correct categorisation of the
status of the gastric mucosa in relation to the presence of IM
and atrophy of the corpus was dependent on the number and
sites of biopsies obtained. The updated Sydney system
recommends two proximal or mid corpus biopsies and may
significantly underestimate the presence of intestinal meta-
plasia/atrophy extending upwards from the antral-corpus
border but not yet reaching the sites recommended by the
Sydney system. Our results suggest that discovery of the
predominant strain being SabA positive might suggest the
presence of hypochlorhydria or achlorhydria and prompt a
search for corpus atrophy.
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